Cargando…
Diminazene aceturate exacerbates renal fibrosis after unilateral ureteral obstruction in female mice
BACKGROUND: Diminazene aceturate (DIZE), an angiotensin-converting enzyme 2 (ACE2) activator, exerts anti-inflammatory and antifibrotic effects in a variety of human chronic diseases. However, the role of DIZE in kidney fibrosis and the underlying mechanism remain unclear. Therefore, we investigated...
Autores principales: | Kim, Yosep, Kim, Jongwan, Han, Sang Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Nephrology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085718/ https://www.ncbi.nlm.nih.gov/pubmed/37037481 http://dx.doi.org/10.23876/j.krcp.22.033 |
Ejemplares similares
-
Diminazene aceturate attenuates hepatic ischemia/reperfusion injury in mice
por: Yoon, So Hye, et al.
Publicado: (2022) -
The Preventive Effects of Diminazene Aceturate in Renal Ischemia/Reperfusion Injury in Male and Female Rats
por: Malek, Maryam, et al.
Publicado: (2014) -
The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice
por: Rajapaksha, Indu G., et al.
Publicado: (2018) -
Development of unstable resistance to diminazene aceturate in Babesia bovis
por: Tuvshintulga, Bumduuren, et al.
Publicado: (2019) -
Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease
por: Velkoska, Elena, et al.
Publicado: (2016)